insights_auto
Why is INO down ၄.၁၃%?
Dive Deeperchevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
၁.၁၆ US$
arrow_downward
-၄.၁၃%(-၀.၀၅၀) 1D
၁.၁၈ US$
arrow_upward
+၁.၆၆% (+၀.၀၁၉)bedtimeAfter hours
Closed: အောက် ၂, GMT-၄ ၁၆:၀၀:၀၁ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
၁.၂၂ US$
High
၁.၂၃ US$
Low
၁.၁၆ US$
Mkt. cap
၁၁.၉၉ ကုဋေ
Avg. vol.
၃.၁၂ သန်း
Volume
၂.၉၂ သန်း
52-wk high
၂.၇၂ US$
52-wk low
၀.၅၇ US$
EPS
-၁.၁၇ US$
Beta
၁.၆၁
Shares outstanding
၁၀.၃၄ ကုဋေ
No. of employees
၁၁၂
Open
၁.၂၂ US$
High
၁.၂၃ US$
Low
၁.၁၆ US$
Mkt. cap
၁၁.၉၉ ကုဋေ
Avg. vol.
၃.၁၂ သန်း
Volume
၂.၉၂ သန်း
52-wk high
၂.၇၂ US$
52-wk low
၀.၅၇ US$
EPS
-၁.၁၇ US$
Beta
၁.၆၁
Shares outstanding
၁၀.၃၄ ကုဋေ
No. of employees
၁၁၂
News stories
From web sources and news partners
Seeking Alpha
·
ပြီးခဲ့သည့် ၁ နာရီ
AI spending to drive another strong S&P 500 earnings season, Goldman Sachs says
Simply Wall Street
·
ပြီးခဲ့သည့် ၁ နာရီ
One MoneyHero Limited (NASDAQ:MNY) Analyst Is Reducing Their Forecasts For This Year
AD HOC NEWS
·
ပြီးခဲ့သည့် ၁၀ မိနစ်
GTIM stock reports stronger fiscal third quarter earnings
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc